- Home
- TLSA vs AMTX Comparison
TLSA vs AMTX Comparison
Compare TLSA & AMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSA
- AMTX
- Stock Information
- Founded
- TLSA 2013
- AMTX 2005
- Country
- TLSA United Kingdom
- AMTX United States
- Employees
- TLSA N/A
- AMTX N/A
- Industry
- TLSA Biotechnology: Pharmaceutical Preparations
- AMTX Major Chemicals
- Sector
- TLSA Health Care
- AMTX Industrials
- Exchange
- TLSA Nasdaq
- AMTX Nasdaq
- Market Cap
- TLSA 187.0M
- AMTX 184.9M
- IPO Year
- TLSA 2000
- AMTX N/A
- Fundamental
- Price
- TLSA $1.86
- AMTX $3.19
- Analyst Decision
- TLSA
- AMTX Strong Buy
- Analyst Count
- TLSA 0
- AMTX 4
- Target Price
- TLSA N/A
- AMTX $13.63
- AVG Volume (30 Days)
- TLSA 242.1K
- AMTX 1.5M
- Earning Date
- TLSA 08-05-2025
- AMTX 08-04-2025
- Dividend Yield
- TLSA N/A
- AMTX N/A
- EPS Growth
- TLSA N/A
- AMTX N/A
- EPS
- TLSA N/A
- AMTX N/A
- Revenue
- TLSA N/A
- AMTX $237,892,000.00
- Revenue This Year
- TLSA N/A
- AMTX $27.81
- Revenue Next Year
- TLSA N/A
- AMTX $91.54
- P/E Ratio
- TLSA N/A
- AMTX N/A
- Revenue Growth
- TLSA N/A
- AMTX N/A
- 52 Week Low
- TLSA $0.63
- AMTX $1.22
- 52 Week High
- TLSA $1.91
- AMTX $4.73
- Technical
- Relative Strength Index (RSI)
- TLSA 70.48
- AMTX 63.11
- Support Level
- TLSA $1.62
- AMTX $2.73
- Resistance Level
- TLSA $1.89
- AMTX $3.38
- Average True Range (ATR)
- TLSA 0.10
- AMTX 0.24
- MACD
- TLSA 0.03
- AMTX -0.01
- Stochastic Oscillator
- TLSA 93.48
- AMTX 49.46
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
About AMTX Aemetis Inc. (DE)
Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries. It owns and operates an approximately 65 million gallon per year ethanol production facility located in Keyes, California. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. It operates in the reportable geographic segments of North America and India.